Gabapentin use and a claim for memory loss in Virginia

Virginia has taken significant regulatory action on gabapentin, classifying it as a Schedule V controlled substance — one of a small number of states to do so. This scheduling reflected Virginia's recognition of gabapentin misuse patterns, particularly in the southwestern Appalachian region where the drug was commonly diverted and co-used with opioids. Virginia's large military and veteran population — concentrated around Hampton Roads, Northern Virginia, and the Quantico-Fort Belvoir corridor — represents a substantial gabapentin-exposed cohort. The state's Eastern District (Norfolk/Richmond) and the Western District (Abingdon/Roanoke) have both seen pharmaceutical litigation, with the coal country of far southwest Virginia among the most heavily gabapentin-impacted areas in the nation.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for Virginia.